Recombinant Human Endostatin(The First Affiliated Hospital of Xinxiang Medical College)

重组人内皮抑素（新乡医学院第一附属医院）

Report date: 2024/02/29 20:00:32

Base Information

Drug NameRecombinant Human Endostatin(The First Affiliated Hospital of Xinxiang Medical College)
Drug Alias Name重组人内皮抑素Endostatin
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionAngiogenesis inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe First Affiliated Hospital Of Xinxiang Medical University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Xinxiang Medical University
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia